Hemolytic Anemias Part 2 Flashcards

1
Q

Thalassemia Syndromes

A

The thalassemia syndromes are a heterogeneous group of disorders caused by inherited mutations that decrease the synthesis of either the α-globin or β-globin chains that compose adult hemoglobin, HbA (α2β2), leading to anemia, tissue hypoxia, and red cell hemolysis related to the * imbalance in globin chain synthesis.*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hemoglobin molecule

A

Hemoglobin A – Tetramer of 4 globin chains + 4 heme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

β-Thalassemias

A

The β-thalassemias are caused by mutations that diminish the synthesis of β-globin chains

β0 mutations, associated with absent β-globin synthesis
β+ mutations, characterized by reduced (but detectable) β-globin synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

β-Thalassemias

Peripheral blood smear

A

Impaired β-globin synthesis results in anemia by two mechanisms.
The deficit in HbA synthesis produces *“underhemoglobinized” hypochromic, microcytic red cells with subnormal oxygen transport capacity.
Even more important is the diminished survival of red cells and their precursors, which results from the imbalance in α- and β-globin synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

severe β-thalassemia

A

it is estimated that * 70% to 85% of red cell precursors suffer diminished survival, which leads to * ineffective erythropoiesis. Those red cells that are released from the marrow also bear inclusions and membrane damage and are prone to splenic sequestration and * extravascular hemolysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

β-Thalassemia Major

A

The anemia manifests 6 to 9 months after birth as hemoglobin synthesis switches from HbF to HbA.
In untransfused patients, hemoglobin levels are 3 to 6 gm/dL

Anisocytosis

Poikilocytosis

Microcytosis

Hypochromia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

β-Thalassemia Minor

A

These patients are usually *asymptomatic. Anemia, if present, is mild. The peripheral blood smear typically shows some red cell abnormalities, including hypochromia, microcytosis, basophilic stippling, and target cells.

Hemoglobin electrophoresis usually reveals an increase in * HbA2 (α2δ2) to 4% to 8% of the total hemoglobin (normal, 2.5% ± 0.3%), which is a reflection of an elevated ratio of δ-chain to β-chain synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Recognition of β-thalassemia trait is important for two reasons:

A

It superficially *resembles the hypochromic microcytic anemia of iron deficiency

It has implications for *genetic counseling. Iron deficiency can usually be excluded through measurement of serum iron, total iron-binding capacity, and serum ferritin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

old male with iron deficiency anemia is what until proven otherwise?

A

colon cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

an anemia that doesnt get better with iron is what until proven otherwise?

A

thalassemia beta minor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The α-thalassemias are caused by

A

inherited deletions that result in reduced or absent synthesis of α-globin chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Alpha Thalassemia Clinical Syndromes

A

Loss one gene: diminishes the production of the alpha globin
protein slightly and patient is “normal” - Silent Carrier.

  1. Loss of two genes: Clinically asymptomatic but microcytic red cells, and at most a mild anemia– Alpha thalassemia Trait.
  2. Loss three genes: Severe anemia, requiring RBC transfusion to survive. Untreated patients die childhood/early adolescence.With three-gene deletion in alpha thalassemia, beta chains (in great excess) begin to associate in tetramers, producing an abnormal hemoglobin, “Hemoglobin H” Disease.
  3. Loss four genes: Incompatible with life – Hydrops Fetalis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

golf ball inclusions are?

A

hemoglobin H, a 3 gene deletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What happens in hydrops fatalis

A

hemoglobin hangs onto the oxygen, baby dies of hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

red cells missing CD 59 and CD55

A

those things keep complement from lysing your RBCs

makes them susceptible when they’re missing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Paroxysmal Nocturnal Hemoglobinuria

A

Paroxysmal nocturnal hemoglobinuria (PNH) is a disease that results from * acquired mutations in the phospha­tidylinositol glycan complementation group A gene (PIGA), an enzyme that is essential for the synthesis of certain membrane-associated complement regulatory proteins.

Red cells deficient in these GPI-linked factors are abnormally susceptible to lysis or injury by complement

at night pH changes

17
Q

PNH blood cells are deficient in three GPI-linked proteins that regulate complement activity:

A

Decay-accelerating factor or CD55
Membrane inhibitor of reactive lysis, or CD59
C8 binding protein

18
Q

Paroxysmal Nocturnal Hemoglobinuria

manifests as

A
  • intravascular hemolysis, which is caused by the C5b-C9 membrane attack complex.

The hemolysis is * paroxysmal and nocturnal in only 25% of cases; chronic hemolysis without dramatic hemoglobinuria is more typical. The tendency for red cells to lyse at night is explained by a slight decrease in blood pH during sleep, which increases the activity of complement.

The anemia is variable but usually mild to moderate in severity. The loss of heme iron in the urine * (hemosiderinuria) eventually leads to iron deficiency, which can exacerbate the anemia if untreated

19
Q

leading cause of disease related death in individuals with PNH:

and other complications that arise

A

Thrombosis.

About 40% of patients suffer from venous thrombosis, often involving the hepatic, portal, or cerebral veins.

About 5% to 10% of patients eventually develop acute myeloid leukemia or a myelodysplastic syndrome, possibly because hematopoietic stem cells have suffered some type of genetic damage.

20
Q

PNH is diagnosed by … and treated with …

A

flow cytometry, which provides a sensitive means for detecting red cells that are deficient in GPI-linked proteins such as CD59.

The cardinal role of complement activation in PNH pathogenesis has been proven by therapeutic use of a monoclonal antibody called Eculizumab that prevents the conversion of C5 to C5a.

This inhibitor not only reduces the hemolysis and attendant transfusion requirements, but also lowers the risk of thrombosis by up to 90%

21
Q

Only acquired hemolytic anemia

A

PNH

22
Q

Direct antiglobulin test

A

= coombs test

antibodies are on the patient’s red cell and –> agglutination

23
Q

Immunohemolytic Anemias are

caused by

A

antibodies that bind to red cells, leading to their premature destruction

Commonly referred to as autoimmune hemolytic anemias

24
Q

warm antibody type

A

igG
primary (idiopathic)
secondary– autoimmune disorder, drugs, lymphoid neoplasms

About 50% of cases are idiopathic (primary); the others are related to a predisposing condition or exposure to a drug.

Most causative antibodies are of the IgG class

Extremely difficult to treat since patient has antibody against their own reds blood cells. This autoantibody also reacts with all other human red cells……… THERE IS NO COMPATIBLE BLOOD FOR TRANSFUSION

25
Q

Cold agglutinin type

A

IgM

acute (mycoplasmal infection, infectious mono)
Chronic- idiopathic, lymphoid neoplasms

Caused by IgM antibodies that bind red cells avidly at low temperatures (0°C to 4°C)

Appear transiently following certain infections, such as with Mycoplasma pneumoniae, Epstein-Barr virus, cytomegalovirus, influenza virus, and human immunodeficiency virus (HIV)

Clinical symptoms result from binding of IgM to red cells in vascular beds where the temperature may fall below 30°C, such as in exposed fingers, toes, and ears

Also seen with CLL***

26
Q

Cold hemolysin type (of IgG)

A

IgG antibodies active below 37 degrees)

rare; occurs mainly in children following viral infections

27
Q

Mechanisms of drug-induced immunohemolytic anemia : antigenic drugs

A

In this setting hemolysis usually follows large, intravenous doses of the offending drug and occurs 1 to 2 weeks after therapy is initiated. These drugs, exemplified by penicillin and cephalosporins, bind to the red cell membrane and are recognized by antidrug antibodies.

28
Q

Mechanisms of drug-induced immunohemolytic anemia :

Tolerance-breaking drugs

A

These drugs, of which the antihypertensive agent α-methyldopa is the prototype, induce in some unknown manner the production of antibodies against red cell antigens, particularly the Rh blood group antigens.

29
Q

About 10% of patients taking α-methyldopa develop

A

autoantibodies, as assessed by the direct Coombs test, and roughly 1% develop clinically significant hemolysis.

30
Q

Cold Hemolysin Type (of IgG)

A

Autoantibodies responsible for an unusual entity known as paroxysmal cold hemoglobinuria

The autoantibodies are IgGs that bind to the P blood group antigen on the red cell surface in cool, peripheral regions of the body. Complement-mediated lysis occurs when the cells recirculate to warm central regions, because the complement cascade functions more efficiently at 37°C.

Most cases are seen in children following viral infections; in this setting the disorder is transient, and most of those affected recover within 1 month.

31
Q

Hemolytic Anemia Resulting from Trauma to Red Cells: cardiac valves

A

The most significant hemolysis caused by trauma to red cells is seen in individuals with cardiac valve prostheses and microangiopathic disorders

Artificial mechanical cardiac valves are more frequently implicated than are bioprosthetic porcine or bovine valves.

The hemolysis stems from shear forces produced by turbulent blood flow and pressure gradients across damaged valves

32
Q

Hemolytic Anemia Resulting from Trauma to Red Cells:

Microangiopathic hemolytic anemia

A

is most commonly seen with disseminated intravascular coagulation, but it also occurs in thrombotic thrombocytopenic purpura (TTP), hemolytic-uremic syndrome (HUS), malignant hypertension, systemic lupus erythematosus, and disseminated cancer

The common pathogenic feature in these disorders is a microvascular lesion that results in luminal narrowing, often due to the deposition of fibrin and platelets

Regardless of the cause, traumatic damage leads to the appearance of red cell fragments (schistocytes), “burr cells,” “helmet cells,” and “triangle cells” in blood smears